Control of serogroup W meningococcal disease outbreaks: the promise of adolescent vaccination
- PMID: 34883092
- PMCID: PMC11841483
- DOI: 10.1016/S2352-4642(21)00349-7
Control of serogroup W meningococcal disease outbreaks: the promise of adolescent vaccination
Conflict of interest statement
We declare no competing interests. The findings and conclusions in this Comment article are those of the authors and do not necessarily represent the official position of the US Centers for Disease Control and Prevention.
Comment on
-
Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study.Lancet Child Adolesc Health. 2021 May;5(5):323-331. doi: 10.1016/S2352-4642(21)00050-X. Epub 2021 Mar 10. Lancet Child Adolesc Health. 2021. PMID: 33711293 Free PMC article.
References
-
- Pace D, Pollard AJ. Meningococcal disease: clinical presentation and sequelae. Vaccine. 2012;30 Suppl 2:B3–9. - PubMed
-
- Christensen H, May M, Bowen L, Hickman M, Trotter CL. Meningococcal carriage by age: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10(12):853–61. - PubMed
-
- European Centers for Disease Control and Prevention. Meningococcal Disease: Recommended Vaccines https://vaccine-schedule.ecdc.europa.eu/Scheduler/ByDisease?SelectedDise... Accessed: October 24, 2021 [
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
